Serum AFP, though widely used as a biomarker for the diagnosis of HCC, lacks specificity for patient surveillance particularly in cirrhotic patients with viral infection or underlying liver disease [14,42]. The gene discussed is AFP; the disease is hepatocellular carcinoma.